ReviewThe Lancet. OncologyPublished
Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)
12 of 36 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Review
- Venue
- The Lancet. Oncology
- Published
- Topic
- Medical imaging
- Subject terms
- Humans; Neuroendocrine Tumors; Receptors, Somatostatin; Radiopharmaceuticals; Positron-Emission Tomography; Treatment Outcome; Delphi Technique; Europe
- PubMed ID
- 42398521
- Added to directory
- Source checked